COMPARATIVE RESISTANCE ANALYSIS BETWEEN CIRRHOTIC AND NON-CIRRHOTIC TREATMENT EXPERIENCED PATIENTS WHO FAILED TREATMENT WITH A COMBINATION OF VANIPREVIR (MK-7009) AND PEGYLATED INTERFERON AND RIBAVIRIN (P/R)

被引:0
|
作者
Ludmerer, S. [1 ]
Barnard, R. [1 ]
Brunhoffer, J. [1 ]
Howe, A. [1 ]
Hwang, P. M. T. [1 ]
Liu, R. [1 ]
Zhou, A. [1 ]
Mobashery, N. [1 ]
机构
[1] Merck & Co Inc, Whitehouse, NJ USA
关键词
D O I
10.1016/S0168-8278(14)61388-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P1228
引用
收藏
页码:S497 / S498
页数:2
相关论文
共 48 条
  • [1] RESISTANCE ANALYSIS OF CIRRHOTIC TREATMENT-EXPERIENCED GENOTYPE 1 PATIENTS IN A STUDY OF MK-7009 IN COMBINATION WITH PEGYLATED INTERFERON/RIBAVIRIN
    Barnard, R.
    Hwang, P. M. T.
    Bhanja, S.
    Campbell, H.
    Strizki, J.
    Cheney, C.
    McHale, C.
    Newhard, W.
    Hazuda, D.
    Mobashery, N.
    Howe, A.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S487 - S487
  • [2] Vaniprevir (MK-7009) Demonstrates Higher Exposures in Treatment-Experienced Genotype (GT) 1 Cirrhotic Than Non-cirrhotic HCV-Infected Patients
    Gao, Wei
    Caro, Luzelena
    Anderson, Melanie
    Hwang, Peggy
    Zhou, Amy
    Su, Jing
    Mobashery, Niloufar
    HEPATOLOGY, 2013, 58 : 739A - 739A
  • [3] SUSTAINED VIRAL RESPONSE AND SAFETY OF MK-7009 IN CIRRHOTIC TREATMENT-EXPERIENCED PATIENTS WITH GENOTYPE 1 HCV INFECTION WHO HAVE FAILED PREVIOUS PEGYLATED INTERFERON AND RIBAVIRIN TREATMENT
    Rodriguez-Torres, M.
    Stoehr, A.
    Gane, E.
    Serfaty, L.
    Lawitz, E.
    Bourque, M.
    Bhanja, S.
    Barnard, R.
    Hwang, P.
    Mobashery, N.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S47 - S47
  • [4] A PHASE 2B STUDY OF MK-7009 (VANIPREVIR) IN PATIENTS WITH GENOTYPE 1 HCV INFECTION WHO HAVE FAILED PREVIOUS PEGYLATED INTERFERON AND RIBAVIRIN TREATMENT
    Lawitz, Eric
    Rodriguez-Torres, Maribel
    Stoehr, Albrecht
    Gane, Edward J.
    Serfaty, Lawrence
    Bhanja, Sanhita
    Barnard, Richard J.
    An, Di
    Gress, Jacqueline
    Hwang, Peggy
    Mobashery, Niloufar
    HEPATOLOGY, 2011, 54 : 1434A - 1435A
  • [5] A phase 2B study of MK-7009 (vaniprevir) in patients with genotype 1 HCV infection who have failed previous pegylated interferon and ribavirin treatment
    Lawitz, Eric
    Rodriguez-Torres, Maribel
    Stoehr, Albrecht
    Gane, Edward J.
    Serfaty, Lawrence
    Bhanja, Sanhita
    Barnard, Richard J.
    An, Di
    Gress, Jacqueline
    Hwang, Peggy
    Mobashery, Niloufar
    JOURNAL OF HEPATOLOGY, 2013, 59 (01) : 11 - 17
  • [6] The addition of vaniprevir (MK-7009) to pegylated-interferon and ribavirin (PR) had a similar health-related quality of life (HRQOL) profile compared to PR alone in non-cirrhotic and cirrhotic chronic hepatitis C (CHC) patients with a prior PR failure
    Arduino, Jean Marie
    Shire, Norah J.
    Mast, T. Christopher
    Zhou, Amy
    Hwang, Peggy
    Mobashery, Niloufar
    HEPATOLOGY, 2013, 58 : 1284A - 1284A
  • [7] Results of combination treatment with pegylated interferon and ribavirin in cirrhotic patients with hepatitis C infection
    Höroldt, B
    Haydon, G
    O'Donnell, K
    Dudley, T
    Nightingale, P
    Mutimer, D
    GUT, 2006, 55 : A43 - A43
  • [8] Results of combination treatment with pegylated interferon and ribavirin in cirrhotic patients with hepatitis C infection
    Horoldt, Barbara
    Haydon, Geoffrey
    O'Donnell, Katrina
    Dudley, Tracey
    Nightingale, Peter
    Mutimer, David
    LIVER INTERNATIONAL, 2006, 26 (06) : 650 - 659
  • [9] SAFETY AND EFFICACY OF VANIPREVIR (MK-7009) IN COMBINATION WITH PEG-INTERFERON ALFA-2A (PEG-IFN)/RIBAVIRIN (RBV) IN GENOTYPE 1 TREATMENT EXPERIENCED HCV-INFECTED JAPANESE PATIENTS
    Hayashi, Norio
    Nakamura, Keisuke
    Wright, Duncan Hamish
    Caro, Luzelena
    Barnard, Richard J.
    Mobashery, Niloufar
    Tanaka, Yoshiyuki
    HEPATOLOGY, 2011, 54 : 996A - 996A
  • [10] Emergence of resistance-associated variants after failed triple therapy with vaniprevir in treatment-experienced non-cirrhotic patients with hepatitis C-genotype 1 infection: A population and clonal analysis
    Barnard, Richard J. O.
    McHale, Carolyn M.
    Newhard, William
    Cheney, Carol A.
    Graham, Donald J.
    Himmelberger, Amy L.
    Strizki, Julie
    Hwang, Peggy M. T.
    Rivera, Amber A.
    Reeves, Jacqueline D.
    Nickle, David
    DiNubile, Mark J.
    Hazuda, Dania J.
    Mobashery, Niloufar
    VIROLOGY, 2013, 443 (02) : 278 - 284